Evidence map›Paper›PMID 23788633›Full record

ReviewCold Spring Harbor perspectives in biology2013

Caspase substrates and inhibitors.

Marcin Poreba, Aleksandra Strózyk, Guy S Salvesen, Marcin Drag

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 107 papers.

0numbers the graph read from it
0cells of the map it votes in
107citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

107 citing papers in PubMed, 190 citations in OpenAlex.

  1. Article
  2. Review
  3. A non-classical necroptosis pathway mediated by caspases.Cell communication and signaling : CCS · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS.Apoptosis : an international journal on programmed cell death · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Exploring caspase functions in mouse models.Apoptosis : an international journal on programmed cell death · 2024
    Review
  16. Review
  17. Review
  18. Evolution of Caspases and the Invention of Pyroptosis.International journal of molecular sciences · 2024
    Review
  19. Article
  20. Article

47 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Marcin PorebaDepartment of Bioorganic Chemistry, Faculty of Chemistry, Wroclaw University of Technology, 50-370 Wrocław, Poland.
Aleksandra Strózyk
Guy S Salvesen
Marcin Drag
Wrocław University of Science and Technology · PLSanford Burnham Prebys Medical Discovery Institute · US

Funding

Survival Mechanisms for Apoptotic CaspaseR01GM099040 · NIGMS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI SALVESEN, GUY S. · 2012 to 2020
$3.8M
NIGMS NIH HHS R01 GM09040NIGMS NIH HHS R01 GM099040
6 · The paper itself

Abstract

Caspases are proteases at the heart of networks that govern apoptosis and inflammation. The past decade has seen huge leaps in understanding the biology and chemistry of the caspases, largely through the development of synthetic substrates and inhibitors. Such agents are used to define the role of caspases in transmitting life and death signals, in imaging caspases in situ and in vivo, and in deconvoluting the networks that govern cell behavior. Additionally, focused proteomics methods have begun to reveal the natural substrates of caspases in the thousands. Together, these chemical and proteomics technologies are setting the scene for designing and implementing control of caspase activity as appropriate targets for disease therapy.

Indexed as

Models, MolecularProtein ConformationApoptosisCaspase InhibitorsCaspasesFluorescenceInflammationMolecular StructureProteomicsSubstrate SpecificityCaspase InhibitorsCaspases

Identifiers

PMID23788633
PMCPMC3721276
OpenAlexW2145967501

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.